Clinical Trials Browser

Unknown × Interventional × Recurrence × Clear all

NCT06149169 2024-08-21

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma

Phase 2 Unknown

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT03275493 2024-05-28

CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04745234 2024-04-25

Mogamulizumab Q4week Dosing in Participants With R/R CTCL

Phase 2 Unknown

DermatologicLymphoid

Recurrence, Lymphoma, T-Cell, Cutaneous

NCT06384482 2024-04-25

SNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine Carcinoma

Phase 1 Unknown

Recurrence

NCT06367114 2024-04-19

Clinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (Including Central Nervous System Infiltration)

Phase 2 Unknown

LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06292858 2024-03-05

Safety/Tolerability, PK and Efficacy of IMB071703 Injection in Patients With Advanced Solid Tumors

Phase 1 Unknown

Neoplasm Metastasis, Recurrence

NCT04739670 2024-03-01

BELLA

Phase 2 Unknown

Recurrence, Triple Negative Breast Neoplasms

NCT03643549 2024-02-29

BORTEM-17

Phase 1/2 Unknown

Glioblastoma, Recurrence

NCT05910970 2024-01-23

PREVENT-2

Phase 3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

NCT05415475 2024-01-05

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors

Phase 1 Unknown

Gastrointestinal

Esophageal Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Recurrence, Stomach Neoplasms, Colorectal Neoplasms

NCT04266327 2023-12-27

RISI in the Treatment of Recurrent Metastatic SCC of Thoracic Inlet Lymph Nodes

Phase NA Unknown

Carcinoma, Squamous Cell, Recurrence

NCT05757466 2023-12-19

Prolgo-HL

Phase 2 Unknown

Hodgkin Disease, Recurrence

NCT03236129 2023-12-18

DLI-Boost

Phase 3 Unknown

Other hematologic neoplasm

Recurrence, Hematologic Neoplasms

NCT04089215 2023-11-24

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma

Phase 2 Unknown

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT06103617 2023-11-18

Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer

Phase 2 Unknown

Head and Neck Neoplasms, Recurrence

NCT02624128 2023-11-13

V-CHANCE

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT05176145 2023-10-13

DMIA

Phase NA Unknown

Non-Muscle Invasive Bladder Neoplasms, Recurrence

NCT06074107 2023-10-11

Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma Subjects

Phase 2 Unknown

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT05626829 2023-10-06

Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma

Phase 2 Unknown

Nasopharyngeal Carcinoma, Recurrence

NCT04825496 2023-09-21

Clinical Study of ssCART-19 Cells in Patients With CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06045585 2023-09-21

JY231 Injection in the Treatment of Relapsed or Refractory B-cell Lymphoma

Phase EARLY_PHASE1 Unknown

Lymphoma, Recurrence, Lymphoma, B-Cell

NCT04969107 2023-08-08

Abdominal or Transanal TME for Rectal Cancer Therapy

Phase NA Unknown

Gastrointestinal

Rectal Neoplasms, Recurrence

NCT03505554 2023-08-07

CRU3

Phase 2 Unknown

Recurrence, Lymphoma, Large-Cell, Anaplastic

NCT05951855 2023-07-19

Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients

Phase 2 Unknown

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT02825836 2023-07-13

Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL Subjects

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT05940051 2023-07-11

Prospective Clinical Study of ZPR Regimen in Relapsed/Refractory Diffuse Large B-cell Lymphoma

Phase 2 Unknown

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT05397184 2023-07-05

TvT CAR7

Phase 1 Unknown

Recurrence

NCT04671459 2023-06-28

TaRRGET

Phase 2 Unknown

Glioblastoma, Recurrence

NCT05576532 2023-06-28

Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia

Phase 2 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Recurrence, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05920876 2023-06-27

A Study of QLS32015 in Patients With Recurrent or Refractory Multiple Myeloma

Phase 1 Unknown

Multiple Myeloma, Recurrence

NCT05250791 2023-06-09

FLICOR

Phase NA Unknown

Gastrointestinal

Recurrence, Colorectal Neoplasms

NCT05895370 2023-06-08

GI-HPVT-01

Phase 1 Unknown

Uterine Cervical Neoplasms, Recurrence

NCT04761146 2023-05-25

DaRT-V

Phase NA Unknown

Recurrence, Vulvar Neoplasms

NCT05876052 2023-05-25

POTERE

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Recurrence

NCT05487651 2023-05-18

ANCHOR2

Phase 1 Unknown

LymphoidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT05105867 2023-05-10

CD19 Targeted Universal Chimeric Antigen Receptor T Cells Injection for CD19+ Refractory/Relapsed B-cell Malignancies

Phase EARLY_PHASE1 Unknown

Burkitt Lymphoma, Recurrence, Lymphoma, B-Cell

NCT05816746 2023-05-09

Decitabine and Anti-PD-1 in R/R DLBCL

Phase 2 Unknown

Extranodal Extension, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT03510767 2023-04-14

A Study of TQ-B3525 on Tolerance and Pharmacokinetics

Phase 1 Unknown

Lymphoma, Recurrence

NCT01675219 2023-04-13

Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9)

Phase 3 Unknown

Urinary Bladder Neoplasms, Recurrence

NCT05797948 2023-04-04

GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Phase NA Unknown

Recurrence, Lymphoma, B-Cell

NCT05084586 2023-03-28

Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation

Phase NA Unknown

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Recurrence

NCT01593488 2023-03-24

CILI

Phase 2 Unknown

CNSLymphoidOther hematologic neoplasm

Central Nervous System Diseases, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04749355 2023-03-09

Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS

Phase 2 Unknown

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT02761070 2023-03-08

RE-GEND

Phase 3 Unknown

Glioblastoma, Recurrence, Disease Progression

NCT04809181 2023-02-21

Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients

Phase 2 Unknown

Other hematologic neoplasm

Recurrence, Hematologic Neoplasms

NCT04933825 2023-02-17

A Study of ET-02 in Patients With Relapsed or Refractory B-cell Malignancy(NHL/ALL)

Phase NA Unknown

Recurrence

NCT05727683 2023-02-14

CD19-targeted CAR T Cells for Patients With Relapsed or Refractory in B-cell Acute Lymphoblastic Leukemia

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04113226 2023-02-08

Relyage

Phase 2 Unknown

LymphoidSarcoma

Recurrence, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

NCT04706936 2023-02-06

Novel BCMA-targeted CAR-T Cell Therapy for Multiple Myeloma

Phase 1 Unknown

Multiple Myeloma, Recurrence

NCT04887025 2023-02-06

Exploratory Study of a Novel Oncolytic Vaccinia Virus RGV004 in the Treatment of Refractory/Relapsed B-cell Lymphoma

Phase 1 Unknown

Recurrence, Lymphoma, B-Cell